Peritoneal carcinomatosis of gynaecological origin

Exam relevance: in 12 of more than 150 board exam reports · rank 59

Specialty
Gynaecology · Ovary & adnexa
Images
Endoscopy & gross 2 · Mammography/MRI 1 · Histology & cytology 2
Exam relevance
12 of more than 150 reports · rank 59
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (5)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Clinical features
  7. Diagnosis
  8. Treatment principles
  9. Keep learning in the app
  10. Further reading (selection)
  11. Cross-references

Images (5)

Peritoneal carcinomatosis of gynaecological origin – endoscopyEndoscopy & gross
Peritoneal carcinomatosis of gynaecological origin – endoscopyImage: Cheng IN, Chang C, Tsai HM, Hsu YT, Huang YF. (Discover oncology 2025) · CC BY 4.0 · Source · cropped
Peritoneal carcinomatosis of gynaecological origin – CT (abdomen, axial, contrast-enhanced): peritoneal carcinomatosis with omental cake – plate-like thickened, tumour-infiltrated omentum just beneath the anterior abdominal wallMammography/MRI
CT (abdomen, axial, contrast-enhanced): peritoneal carcinomatosis with omental cake – plate-like thickened, tumour-infiltrated omentum just beneath the anterior abdominal wallImage: Subhaschandra Singh, Y. Sobita Devi, Shweta Bhalothia and Dr. Veeraraghavan Gunasekaran (Wikimedia Commons) · CC BY 4.0 · Source
Peritoneal carcinomatosis of gynaecological origin – Histology (H&E): omental deposit of serous carcinoma (presumed ovarian origin) – atypical tumour cell nests with psammoma bodies (dark calcified spheres)Histology & cytology
Histology (H&E): omental deposit of serous carcinoma (presumed ovarian origin) – atypical tumour cell nests with psammoma bodies (dark calcified spheres)Image: Nephron, “Serous carcinoma - omentum -- high mag” (Wikimedia Commons) · CC BY-SA 3.0 · Source
Peritoneal carcinomatosis of gynaecological origin – endoscopyEndoscopy & gross
Peritoneal carcinomatosis of gynaecological origin – endoscopyImage: Cheng IN, Chang C, Tsai HM, Hsu YT, Huang YF. (Discover oncology 2025) · CC BY 4.0 · Source · cropped
Peritoneal carcinomatosis of gynaecological origin – Histology (H&E): serous carcinoma in the omentum – tumour cell clusters infiltrating desmoplastic stroma and adipose tissue (right)Histology & cytology
Histology (H&E): serous carcinoma in the omentum – tumour cell clusters infiltrating desmoplastic stroma and adipose tissue (right)Image: Nephron, “Serous carcinoma - omentum 2 -- high mag” (Wikimedia Commons) · CC BY-SA 3.0 · Source
1 / 5

Definition

  • Peritoneal surface malignancies are tumours arising from or spreading to the peritoneum, including primary peritoneal tumours, pseudomyxoma peritonei and peritoneal carcinomatosis from gastrointestinal or gynaecological primaries.
  • Peritoneal carcinomatosis is the implantation of neoplastic cells in the peritoneal cavity; it is often multifocal, appearing as widespread nodules or mucinous deposits.

Classification

  • Mucinous, non-mucinous and primary peritoneal forms are distinguished.
  • The Sugarbaker Peritoneal Cancer Index (PCI) records the distribution and size of deposits in nine abdominopelvic regions and four small bowel regions.
  • In each region the lesion size is graded: no tumour, nodules under 0.5 cm, 0.5–5 cm or over 5 cm.

Occurrence & epidemiology

Epidemiology

  • In ovarian cancer about 70% of patients are diagnosed at an advanced stage (FIGO III–IV) or with peritoneal carcinomatosis.
  • Peritoneal carcinomatosis is also relatively frequent in advanced stages of many gastrointestinal tumours such as colonic, gastric and pancreatic cancer.

Aetiopathogenesis

Pathogenesis

  • Ovarian cancer usually spreads within the abdomen via the peritoneal circulation.
  • Peritoneal fluid flows from the pelvis via the paracolic gutters to the subdiaphragmatic regions, drawn by negative pressure as the diaphragm rises during expiration; on the right it reaches the anterior subhepatic and right hepatic spaces.
  • On the left the phrenicocolic ligament limits flow towards the perisplenic spaces.

Clinical features

  • Complications are malignant ascites, bowel obstruction and malnutrition.

Diagnosis

  • According to international guidelines CT is the standard imaging modality for ovarian cancer staging, with an accuracy of up to 94%, and assesses the primary tumour, peritoneal implants, lymph nodes and distant metastases.
  • MRI helps where CT is inadequate, such as subphrenic spaces, the lesser omentum and serosal and mesenteric deposits.
  • The diagnosis relies on cross-sectional imaging, histology of the implants and tumour markers such as CEA or CA 125; laparoscopy can confirm the extent and allow tissue sampling.

Treatment principles

  • Treatment depends on the primary tumour and is decided in an interdisciplinary tumour board; in ovarian cancer, peritoneal carcinomatosis is part of advanced-stage disease.
  • Where achievable, the aim is complete surgical cytoreduction in an experienced centre combined with systemic therapy; intraperitoneal techniques are reserved for selected situations.
  • In the palliative setting, symptom control, such as drainage of ascites, and early involvement of palliative care are the priorities.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Peritoneal carcinomatosis of gynaecological origin with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Peritoneal Surface Malignancies (NCBI Bookshelf)

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Mature cystic teratoma (dermoid cyst) · Tubo-ovarian abscess · Pelvic inflammatory disease (PID)

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.